2026-10-29 18:05:00 UTC#539703newconfirmednews
Labcorp (LH) stock news
Labcorp (LH) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-29 16:20:00 UTC#538986updateconfirmednews
Labcorp Holdings Inc. average analyst price target raised to $373.20, implying 4% upside
2026-10-29 15:12:57 UTC#538587newconfirmednews
Barclays maintains Labcorp Holdings at Equal-Weight, raises price target to $380 from $330
2026-10-28 19:20:00 UTC#531728newconfirmednews
Labcorp Holdings Inc. average analyst price target raised to $353.60, implying 7% upside
2026-10-28 16:52:00 UTC#530708duplicateconfirmednews
Labcorp Holdings shares rise following Q3 earnings beat and raised full-year guidance
2026-10-28 15:09:48 UTC#529990updateconfirmednews
Labcorp Holdings Q3 revenue up 6.9%, adjusted EPS up 14.5%; FY26 guidance raised despite 2027 PAMA headwinds
2026-10-28 12:57:04 UTC#528915newconfirmednews
Laboratory Corporation of America Holdings (Labcorp) Q3 2026 earnings call begins
2026-10-28 10:52:00 UTC#527892newconfirmedpress release
Labcorp Holdings reaffirms 2026 free cash flow guidance of $1.24B to $1.36B
2026-10-28 10:52:00 UTC#527891updateconfirmeddata release
Labcorp Holdings issues 2026 revenue guidance of $14.71B to $14.83B
2026-10-28 10:52:00 UTC#527890updateconfirmednews
Labcorp Holdings issues 2026 adjusted EPS guidance of $18.10 to $18.55
2026-10-28 10:51:31 UTC#527885duplicateconfirmednews
Labcorp Holdings Q3 2026 Non-GAAP EPS $4.78 beats by $0.14, Revenue $3.81B beats by $50M, Raises FY Guidance
2026-10-28 10:51:01 UTC#527903duplicateconfirmednews
Labcorp Q3 Revenue $3.81B vs $3.759B Est, Adj EPS $4.78; FY Revenue Outlook $14.779B-$14.887B
2026-10-28 10:51:00 UTC#527910updateconfirmednews
Labcorp Holdings raises 2026 revenue guidance to $14.78B-$14.89B
2026-10-28 10:50:00 UTC#527859newconfirmedpress release
Labcorp Q3 2026 Revenue $3.81B vs $3.56B, Adj EPS $4.78 vs $4.18; Raises Full-Year Guidance
2026-10-27 17:46:05 UTC#523219newforecastanalysis
Labcorp Holdings Q3 2026 Earnings Preview
2026-10-23 12:21:04 UTC#506517newconfirmednews
Waters and Labcorp to offer BD Onclarity HPV assay for cervical cancer screening by late 2026
reutersimportance 0.40trust 0.80Waters Corporation +0.30Labcorp Holdings Inc. +0.30Becton, Dickinson and Company +0.30+1 entities
2026-10-22 22:19:29 UTC#503265newconfirmednews
Charles River, Labcorp, and FDA Partner to Standardize Preclinical Abuse Potential Assessment Metrics
reutersimportance 0.40trust 0.90Charles River Laboratories International, Inc. +0.30Laboratory Corporation of America Holdings +0.30U.S. Food and Drug Administration +0.30
2026-10-21 18:35:00 UTC#495005newconfirmedpress release
OPKO Health to sell select BioReference Health assets to Labcorp for over $722 million
pr newswireimportance 0.60trust 0.90OPKO Health, Inc. +0.40Labcorp Holdings Inc. +0.30BioReference Health, LLC -0.30+1 entities
2026-10-21 10:50:00 UTC#492316newconfirmedpress release
Labcorp declares quarterly cash dividend of $0.72 per share payable December 11, 2026
2026-10-20 13:27:31 UTC#486737duplicateconfirmednews
Myriad Genetics to sell prenatal health business to Labcorp for $210 million
seeking alphaimportance 0.30trust 0.70Myriad Genetics, Inc. +0.20Laboratory Corporation of America Holdings +0.20